Find a Tender
planning
Official procurement procedure
Provision of Analysers and Consumables to Test Total Protein Assays from Apheresis Donors and Donations
Analysers
UK
Published value
£1,260,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Provision of Analysers and Consumables to Test Total Protein Assays from Apheresis Donors and Donations". Published status: planning. Published value: £1,260,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Blood and Transplant | Scope & Categories | Not published | Submission Window | planning No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £1,260,000 |
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.9Bids / Report
Supplier ConcentrationHigh Concentration
Carmelcrest LtdTop vendor: 66.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 65 active published awards; 20 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Carmelcrest Ltd | 1 win | £1,098,370 |
| Jobtrain Limited | 2 wins | £186,954 |
| CRYOPDP | 1 win | £108,014 |
| Arctic Shores Limited | 1 win | £93,000 |
| Osteopaths For Industry Limited | 1 win | £60,000 |
Procedure terms
Contracting AuthorityNHS Blood and Transplant | Procedure methodNot published | Procurement categoryNot published |
Statusplanning | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Feb 2026, 08:36 GMT | Last source update6 Feb 2026, 08:36 GMT | Recurring procurementNot published |
ClassificationAnalysers | ||
Delivery area UK | ||
OCIDocds-h6vhtk-064996 | ||
What is being bought
NHS Blood and Transplant (NHSBT) are responsible for collecting plasma and platelet donations in England. There is a requirement for NHSBT to undertake total protein testing on these donations and the donors.
As part of the preliminary market engagement exercise, NHSBT are seeking to engage with potential suppliers of analysers that can run total protein assays.
1. General Requirements – Background:
For Donor Safety:
All apheresis donors require a total protein test on their first donation, and this is repeated at every 8th donation and at least annually. Total protein must not be less than 60g/L.
For Quality Monitoring:
Total protein is tested in:
a. 1% of recovered plasma donations (from whole blood donations);
b. 1% of apheresis plasma donations; and
c. 1% of concurrent apheresis plasma donations (obtained during platelet donation).
Total protein must not be less than 50g/L.
NHSBT currently outsource this testing to a 3rd Party. NHSBT are considering bringing this testing in house from 2027. Please note a final decision has not been made on this and the information obtained from this preliminary market engagement will help to inform the decision.
2. Requirement:
NHSBT potentially has a requirement for the purchase/loan of up to three analysers that can run special protein assays. Whilst total protein testing is the primary requirement, NHSBT may also be looking to test for immunoglobulins (IgG) and albumin as part of the requirement. As a general overview, the contracted supplier would be responsible for:
a. Providing analysers that can test for total protein, and ideally, also IgG and Albumin. This includes delivery of the machines to one/all of the three manufacturing sites – located at Filton, Colindale and Manchester;
b. Providing key consumables including assay-specific reagents;
c. Potentially providing the software (including training) to analyse the results – note: this requirement is still under consideration; and
d. Providing a maintenance and repair service to cover all planned maintenance and any repairs.
3. Contract Duration:
The contract duration is still under consideration. The market engagement will enquire about machine lifespan which will further inform the contract length. The current assumption is 5 years plus 2 x 1-year options. The estimated contract value is based on 7 years.
What changed
From the official release history
- Published value updated to £1,260,000
6 Feb 2026, 08:36 GMT - Status changed to planning
6 Feb 2026, 08:36 GMT - Official notice release published
6 Feb 2026, 08:36 GMT - Buyer information updated
6 Feb 2026, 08:36 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplanningPublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Pipeline notice
6 Feb 2026, 08:36 GMT - Procedure published
6 Feb 2026, 08:36 GMT - engagement
28 Feb 2026, 23:59 GMT · scheduledIf you are interested in taking part in the market engagement, please contact: james.marshall2@nhsbt.nhs.uk by no later than 12:00 hrs (GMT) on 28/02/2026. Market engagement is likely to take place via a questionnaire and potentially video calls in March 2026. There is no guarantee that a formal procurement process will be launched as a result of this preliminary market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this preliminary market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Blood and Transplant
Contracting authority GB-PPON-PDBY-6395-VWBPDocuments (1)
Official links; attachments are not copied
- 6 Feb 2026, 08:36 GMT
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |